Search Results
Slidesets
HCV infection and liver steatosis- George Lau, MD, MBBS, MRCP
Presented at:
Asian Conference on Hepatitis and AIDS (ACHA) 2017
Slidesets
Pharmacological Considerations in Optimal Integrase Inhibitors Clinical Care - David Back
Presented at:
Spanish HIV Clinical Forum 2016
Slidesets
Acquired Drug Resistance: Causes, Patterns, and Implications for SSA | Coumba Toure Kane, PharmD, PhD
Presented at:
INTEREST 2016
Slidesets
Local Situation in Baltic Countries | Saulius Caplinskas, MD, PhD
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and Co-infection with HIV 2015
Slidesets
Program - Viral Infections & Inflammation Workshop 2022
Presented at:
Viral Infections & Inflammation Workshop 2022
Slidesets
Drug-Drug Interactions between Small Molecule Inhibitors with Directly-Acting Oral Anti-coagulants (DOACs) in Patients with Lung Cancer. | Lorenz Van der Linden, PharmD, PhD
Presented at:
Pharmacological Optimization of Lung Cancer Treatment Webinar: Drug-Drug Interactions, Therapeutic Drug Monitoring, and Immunotherapy
Slidesets
ART Simplification Strategy - Pedro Cahn, MD, PhD
Presented at:
São Paulo HIV Clinical Forum 2022
Slidesets
Reduced Drug Regimes Data and Implementation - Anton Pozniak, MD, FRCP
Presented at:
Russian HIV Clinical Forum 2019
Slidesets
Translating Exercise into the community with adults aging with HIV- Kelly O’Brien, PhD, PT
Presented at:
International Workshop on HIV & Aging 2018